DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Afloqualone
Afloqualone
Afloqualone
Ep 0665009 A1
Marrakesh Agreement Establishing the World Trade Organization
L:\0901 with Peru\0901PHARMAPPX.Wpd
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
GABA Receptor Gamma-Aminobutyric Acid Receptor; Γ-Aminobutyric Acid Receptor
Supplement Ii to the Japanese Pharmacopoeia Seventeenth Edition
Design, Synthesis, Molecular Docking and Anticonvulsant Evaluation of Novel 6-Iodo-2-Phenyl- 3-Substituted-Quinazolin-4(3H)-Ones
Infrared Reference Spectra
Accidental Afloqualone Intoxication in Two Dogs
Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
The Effect of Different Doses of Oral Tizanidine, on the Minimum Alveolar Concentration of Isoflurane and Stress Response
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Customs Tariff - Schedule
Afloqualone SAFETY DATA SHEET Section 2. Hazards Identification
Anatomical Classification Guidelines V2016
Top View
Wo 2010/103544 A2
Transdermal Device Containing
General Information
Mechanisms of Photosensitization Induced by Drugs: a General Survey 27
(12) United States Patent (10) Patent No.: US 8,414.914 B2 Bromley Et Al
Customs Tariff - Schedule Xxi - 1
Substance Abuse in the Workplaces of Our Bodies and Mind
Copyrighted Material
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2006) (Rev
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
Quinazolinone (Afloqualone), a New Centrally Acting Muscle Relaxant (I)
WO 2U11/132171 Al
Customs Tariff - Schedule
ICD-10-CM TABLE of DRUGS and CHEMICALS
New Psychoactive Substances Edition 3
Pharmaceutical Appendix to the Tariff Schedule 2
Meta-Analysis of Empirical Studies Concerning the Effects of Medicines and Illegal Drugs Including Pharmacokinetics on Safe Driving
1 Human UGT2B10 in Drug N-Glucuronidations: Substrate Screening
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
ICD-10-CM Table of Drugs 2019
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
L:\0900\0900PHARMAPPX .Wpd
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
Toxicology Reference Material